Biotechnology Monster
Washington D.C. Metro Area
- Current
-
- Intern, Office of Biotechnology Products at FDA Center for Drug Evaluation and Research
- Lead Organizer at BIL:PIL Healthcare Innovation Conference
- Past
-
- Senior Biopharmaceutical Representative, Dermatology at Amgen
- Marketing Analysis Manager at Amgen
- Business Analyst at Accenture
- Research Assistant at Broad Institute
- Program Manager Intern at Microsoft
- Consultant at OPNET Technologies
- Independent Developer at Transoft, Inc.
- Bioinformatics Intern at Pfizer Discovery Technology Center
- Summer Intern at Merrill Lynch Intelligent Technologies Group
- Education
-
- Harvard Business School
- Massachusetts Institute of Technology
- Massachusetts Institute of Technology
- Massachusetts Institute of Technology
- Commonwealth School
- Recommended
-
2 people have recommended Jonathan - Connections
-
500+
connections
- Industry
- Biotechnology
- Websites
Jonathan Sheffi’s Summary
Biotechnology professional with a fiery passion for innovative products that improve patients’ lives. With my strategic marketing experience, wealth of analytical skills, and up-to-date knowledge of the competitive landscape, I want to drive a biotechnology company's ability to identify and pursue major market opportunities.
I combine a broad view of the pharmaceutical value chain with deep experience in the biotechnology industry. I have comfortably and knowledgeably worked with business development, finance, sales, marketing, contracting, market research, managed markets, R&D, and supply chain management functions.
Jonathan Sheffi’s Specialties:
Sales, marketing analysis, competitive intelligence, primary and secondary market research, financial modeling
Jonathan Sheffi’s Experience
-
Intern, Office of Biotechnology Products
FDA Center for Drug Evaluation and Research
(Government Agency; Government Administration industry)
May 2009 — Present (3 months)
Analyze adverse event data to determine sources of manufacturing error for biologic therapies and inform policy on interchangeability of possible follow-on biologics.
Classwork: New Reviewer Workshop, NDA Regulations and Policies, Introduction to Drug Law & Regulation, Introduction to Biologics Law. -
Lead Organizer
BIL:PIL Healthcare Innovation Conference
(Biotechnology industry)
February 2009 — Present (6 months)
-
Senior Biopharmaceutical Representative, Dermatology
Amgen
(Public Company; AMGN; Biotechnology industry)
2007 — 2009 (2 years)
As a senior biopharmaceutical representative, I educated dermatologists in the Portland, OR territory about Enbrel, a biologic indicated for psoriasis and psoriatic arthritis, and I suggested its use in appropriate patients. I synthesized information about customer needs to deliver appropriate messages to physicians about the clinical safety and efficacy of our product, and I trained clinical staff on supportive materials.
-
Marketing Analysis Manager
Amgen
(Public Company; AMGN; Biotechnology industry)
2006 — 2007 (1 year)
As the secondary market research manager for the Aranesp and Sensipar brand teams, I not only provided the accurate analysis and insights that our marketing teams need to understand their businesses at a deep level, but also proactively crafted projects with high strategic value, ensuring our brands' positions as the leading therapies for patients suffering from chronic kidney disease and secondary hyperparathyroidism.
-
Business Analyst
Accenture
(Public Company; 10,001 or more employees; ACN; Management Consulting industry)
2004 — 2006 (2 years)
As a business analyst, I supported our client strategy teams within the pharmaceuticals and medical products industry. Through the construction of data-driven models and preparation of market research, I provided the quantitative and qualitative insight and analysis that our clients needed.
Projects included:
* Support for the Managed Markets Director of a top pharma. I designed new analyses to evaluate an ongoing Medicare Part D campaign. I analyzed Part D access levels for each brand and suggested strategic investments at the regional level.
* Cross-portfolio marketing mix optimization for a top pharma. Our team analyzed marketing investments at the regional and market segment levels to determine the ROI for each channel, providing brand budget recommendations.
* Clinical drug development strategy for a network of cancer clinics. Our team guided the client through initial vision-setting and influenced selection of target therapeutic areas and partner clinics. -
Research Assistant
Broad Institute
(Educational Institution; Biotechnology industry)
2003 — 2004 (1 year)
The Broad Institute (formerly the Whitehead Institute Center for Genome Research) is a world-class research institution whose mission is to bring new powerful tools for genomic medicine to the global scientific community and apply them to the understanding and treatment of disease.
As a master’s student and research assistant, I worked in a small team to design and implement a novel algorithm that accurately and concisely models human genomic variation and will enable more powerful and insightful disease association studies.
In March 2004, I presented the algorithm at a poster session at the Research in Computational Molecular Biology (RECOMB) conference before an audience of hundreds of attendees. -
Program Manager Intern
Microsoft
(Public Company; 10,001 or more employees; MSFT; Computer Software industry)
May 2003 — August 2003 (4 months)
As a program manager intern, I coordinated a team of developers and testers towards the design and implementation of new user interface features in a bug tracking and test case management tool.
The new features, which included a spelling checker and a “Big Bug ID,” had been highly sought-after by our users and were welcomed as productivity enhancements. -
Consultant
OPNET Technologies
(Public Company; 201-500 employees; OPNT; Computer Networking industry)
March 2003 — April 2003 (2 months)
Evaluated software release for both functionality and ease of use. Reported directly to senior management.
-
Independent Developer
Transoft, Inc.
(Computer Software industry)
1997 — 2003 (6 years)
I created ShipSmart, a supply chain optimization tool intended for educational use. The tool demonstrated how variability in both market demand and transportation services affect optimal shipment size and shipping frequency.
I was solely responsible for the design, development, implementation, testing, documentation, deployment and support of this product.
In April 2000, I guest-lectured to an Advanced Transportation Management class at the Smith School of Business at the University of Maryland on the topic of supply chain optimization and related applications.
In June 2003, I sold ShipSmart and all related intellectual property to the University of Maryland at College Park. -
Bioinformatics Intern
Pfizer Discovery Technology Center
(Public Company; 10,001 or more employees; PFE; Pharmaceuticals industry)
June 2002 — August 2002 (3 months)
As a bioinformatics intern in the Molecular Informatics Division, I expedited the drug discovery process through the implementation of a 3D cluster analysis algorithm to computationally identify enzyme active sites.
I saved wet lab time for Pfizer scientists by implementing a recursive-partitioning algorithm to computationally predict the activity levels of both known and hypothetical compounds. -
Summer Intern
Merrill Lynch Intelligent Technologies Group
(Public Company; 10,001 or more employees; MER; Financial Services industry)
May 2000 — August 2000 (4 months)
Jonathan Sheffi’s Education
-
Harvard Business School
MBA , 2009 — 2011 (expected)
-
Massachusetts Institute of Technology
MEng , Electrical Engineering and Computer Science (Field: Computational Biology) , 2003 — 2004
Thesis titled "An HMM-based Boundary-flexible Model of Human Haplotype Variation." Thesis received David Adler Memorial Thesis Prize by the MIT EECS department for best Master’s thesis of 2003-2004. 1st of approximately 200 students.
- Activities and Societies:
- Tau Beta Pi, Sigma Xi, Eta Kappa Nu
-
Massachusetts Institute of Technology
SB , Computer Science and Engineering , 1999 — 2003
Biology minor.
- Activities and Societies:
- Resonance a capella, Musical Theater Guild, Tau Beta Pi, Sigma Xi, Eta Kappa Nu.
-
Massachusetts Institute of Technology
SB , Mathematics , 1999 — 2003
Biology minor.
- Activities and Societies:
- Resonance a capella, Musical Theater Guild, Tau Beta Pi, Sigma Xi, Eta Kappa Nu.
-
Commonwealth School
Additional Information
Jonathan Sheffi’s Websites:
Jonathan Sheffi’s Interests:
Meditation, basketball, soccer, puzzles, theater.
Jonathan Sheffi’s Honors:
* Amgen Biopharmaceutical Sales Representative of the Quarter, West Region (Q1 2008).
* Amgen Team Excellence Award for district with strongest sales performance to goal (2008).
* District Rookie of the Year Award for best new biopharmaceutical sales representative (2008).
* David Adler Memorial Thesis Prize, first place. (2004)
* MIT Mystery Hunt, winner. (2002, 2006, 2008)
Jonathan Sheffi’s Contact Settings
Interested In:
- career opportunities
- consulting offers
- new ventures
- job inquiries
- expertise requests
- business deals
- reference requests
- getting back in touch
